Does total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia?

Mitchell Sabloff, Ronald M. Sobecks, Kwang Woo Ahn, Xiaochun Zhu, Marcos de Lima, Jennifer R. Brown, Yoshihiro Inamoto, H. Kent Holland, Mahmoud D. Aljurf, Mary J. Laughlin, Rammurti T. Kamble, Jack W. Hsu, Baldeep M. Wirk, Matthew Seftel, Ian D. Lewis, Mukta Arora, Edwin P. Alyea, Matt E. Kalaycio, Jorge Cortes, Richard T. MaziarzRobert Peter Gale, Wael Saber

Research output: Contribution to journalArticle

Abstract

An allogeneic hematopoietic cell transplantation from an HLA-identical donor after high-dose (myeloablative) pretransplantation conditioning is an effective therapy for some people with chronic lymphocytic leukemia (CLL). Because CLL is a highly radiosensitive cancer, we hypothesized that total body irradiation (TBI) conditioning regimens may be associated with better outcomes than those without TBI. To answer this, we analyzed data from 180 subjects with CLL receiving myeloablative doses of TBI (n=126) or not (n=54), who received transplants from an HLA-identical sibling donor between 1995 and 2007 and reported to the Center for International Blood & Marrow Transplant Research. At 5years, treatment-related mortality was 48% (95% confidence interval [CI], 39% to 57%) versus 50% (95% CI, 36% to 64%); P= NS. Relapse rates were 17% (95% CI, 11% to 25%) versus 22% (95% CI, 11% to 35%); P= NS. Five-year progression-free survival and overall survival were 34% (95% CI, 26% to 43%) versus 28% (95% CI, 15% to 42%); P= NS and 42% (95% CI, 33% to 51%) versus 33% (95% CI, 19% to 48%); P= NS, respectively. The single most common cause of death in both cohorts was recurrent/progressive CLL. No variable tested in the multivariate analysis was found to significantly affect these outcomes, including having failed fludarabine. Within the limitations of this study, we found no difference in HLA-identical sibling transplantation outcomes between myeloablative TBI and chemotherapy pretransplantation conditioning in persons with CLL.

Original languageEnglish (US)
Pages (from-to)421-424
Number of pages4
JournalBiology of Blood and Marrow Transplantation
Volume20
Issue number3
DOIs
StatePublished - Mar 1 2014
Externally publishedYes

Fingerprint

Whole-Body Irradiation
B-Cell Chronic Lymphocytic Leukemia
HLA Antigens
Transplantation
Confidence Intervals
Transplants
Cell Transplantation
Disease-Free Survival
Cause of Death
Multivariate Analysis
Bone Marrow
Recurrence
Drug Therapy
Survival
Mortality
Therapeutics
Research

Keywords

  • Chronic lymphocytic leukemia
  • Conditioning
  • Myeloablative
  • Total body irradiation

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Does total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia? / Sabloff, Mitchell; Sobecks, Ronald M.; Ahn, Kwang Woo; Zhu, Xiaochun; de Lima, Marcos; Brown, Jennifer R.; Inamoto, Yoshihiro; Holland, H. Kent; Aljurf, Mahmoud D.; Laughlin, Mary J.; Kamble, Rammurti T.; Hsu, Jack W.; Wirk, Baldeep M.; Seftel, Matthew; Lewis, Ian D.; Arora, Mukta; Alyea, Edwin P.; Kalaycio, Matt E.; Cortes, Jorge; Maziarz, Richard T.; Gale, Robert Peter; Saber, Wael.

In: Biology of Blood and Marrow Transplantation, Vol. 20, No. 3, 01.03.2014, p. 421-424.

Research output: Contribution to journalArticle

Sabloff, M, Sobecks, RM, Ahn, KW, Zhu, X, de Lima, M, Brown, JR, Inamoto, Y, Holland, HK, Aljurf, MD, Laughlin, MJ, Kamble, RT, Hsu, JW, Wirk, BM, Seftel, M, Lewis, ID, Arora, M, Alyea, EP, Kalaycio, ME, Cortes, J, Maziarz, RT, Gale, RP & Saber, W 2014, 'Does total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia?', Biology of Blood and Marrow Transplantation, vol. 20, no. 3, pp. 421-424. https://doi.org/10.1016/j.bbmt.2013.11.032
Sabloff, Mitchell ; Sobecks, Ronald M. ; Ahn, Kwang Woo ; Zhu, Xiaochun ; de Lima, Marcos ; Brown, Jennifer R. ; Inamoto, Yoshihiro ; Holland, H. Kent ; Aljurf, Mahmoud D. ; Laughlin, Mary J. ; Kamble, Rammurti T. ; Hsu, Jack W. ; Wirk, Baldeep M. ; Seftel, Matthew ; Lewis, Ian D. ; Arora, Mukta ; Alyea, Edwin P. ; Kalaycio, Matt E. ; Cortes, Jorge ; Maziarz, Richard T. ; Gale, Robert Peter ; Saber, Wael. / Does total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia?. In: Biology of Blood and Marrow Transplantation. 2014 ; Vol. 20, No. 3. pp. 421-424.
@article{6cf8a6a0e1ac4289b400f71089e22248,
title = "Does total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia?",
abstract = "An allogeneic hematopoietic cell transplantation from an HLA-identical donor after high-dose (myeloablative) pretransplantation conditioning is an effective therapy for some people with chronic lymphocytic leukemia (CLL). Because CLL is a highly radiosensitive cancer, we hypothesized that total body irradiation (TBI) conditioning regimens may be associated with better outcomes than those without TBI. To answer this, we analyzed data from 180 subjects with CLL receiving myeloablative doses of TBI (n=126) or not (n=54), who received transplants from an HLA-identical sibling donor between 1995 and 2007 and reported to the Center for International Blood & Marrow Transplant Research. At 5years, treatment-related mortality was 48{\%} (95{\%} confidence interval [CI], 39{\%} to 57{\%}) versus 50{\%} (95{\%} CI, 36{\%} to 64{\%}); P= NS. Relapse rates were 17{\%} (95{\%} CI, 11{\%} to 25{\%}) versus 22{\%} (95{\%} CI, 11{\%} to 35{\%}); P= NS. Five-year progression-free survival and overall survival were 34{\%} (95{\%} CI, 26{\%} to 43{\%}) versus 28{\%} (95{\%} CI, 15{\%} to 42{\%}); P= NS and 42{\%} (95{\%} CI, 33{\%} to 51{\%}) versus 33{\%} (95{\%} CI, 19{\%} to 48{\%}); P= NS, respectively. The single most common cause of death in both cohorts was recurrent/progressive CLL. No variable tested in the multivariate analysis was found to significantly affect these outcomes, including having failed fludarabine. Within the limitations of this study, we found no difference in HLA-identical sibling transplantation outcomes between myeloablative TBI and chemotherapy pretransplantation conditioning in persons with CLL.",
keywords = "Chronic lymphocytic leukemia, Conditioning, Myeloablative, Total body irradiation",
author = "Mitchell Sabloff and Sobecks, {Ronald M.} and Ahn, {Kwang Woo} and Xiaochun Zhu and {de Lima}, Marcos and Brown, {Jennifer R.} and Yoshihiro Inamoto and Holland, {H. Kent} and Aljurf, {Mahmoud D.} and Laughlin, {Mary J.} and Kamble, {Rammurti T.} and Hsu, {Jack W.} and Wirk, {Baldeep M.} and Matthew Seftel and Lewis, {Ian D.} and Mukta Arora and Alyea, {Edwin P.} and Kalaycio, {Matt E.} and Jorge Cortes and Maziarz, {Richard T.} and Gale, {Robert Peter} and Wael Saber",
year = "2014",
month = "3",
day = "1",
doi = "10.1016/j.bbmt.2013.11.032",
language = "English (US)",
volume = "20",
pages = "421--424",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Does total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia?

AU - Sabloff, Mitchell

AU - Sobecks, Ronald M.

AU - Ahn, Kwang Woo

AU - Zhu, Xiaochun

AU - de Lima, Marcos

AU - Brown, Jennifer R.

AU - Inamoto, Yoshihiro

AU - Holland, H. Kent

AU - Aljurf, Mahmoud D.

AU - Laughlin, Mary J.

AU - Kamble, Rammurti T.

AU - Hsu, Jack W.

AU - Wirk, Baldeep M.

AU - Seftel, Matthew

AU - Lewis, Ian D.

AU - Arora, Mukta

AU - Alyea, Edwin P.

AU - Kalaycio, Matt E.

AU - Cortes, Jorge

AU - Maziarz, Richard T.

AU - Gale, Robert Peter

AU - Saber, Wael

PY - 2014/3/1

Y1 - 2014/3/1

N2 - An allogeneic hematopoietic cell transplantation from an HLA-identical donor after high-dose (myeloablative) pretransplantation conditioning is an effective therapy for some people with chronic lymphocytic leukemia (CLL). Because CLL is a highly radiosensitive cancer, we hypothesized that total body irradiation (TBI) conditioning regimens may be associated with better outcomes than those without TBI. To answer this, we analyzed data from 180 subjects with CLL receiving myeloablative doses of TBI (n=126) or not (n=54), who received transplants from an HLA-identical sibling donor between 1995 and 2007 and reported to the Center for International Blood & Marrow Transplant Research. At 5years, treatment-related mortality was 48% (95% confidence interval [CI], 39% to 57%) versus 50% (95% CI, 36% to 64%); P= NS. Relapse rates were 17% (95% CI, 11% to 25%) versus 22% (95% CI, 11% to 35%); P= NS. Five-year progression-free survival and overall survival were 34% (95% CI, 26% to 43%) versus 28% (95% CI, 15% to 42%); P= NS and 42% (95% CI, 33% to 51%) versus 33% (95% CI, 19% to 48%); P= NS, respectively. The single most common cause of death in both cohorts was recurrent/progressive CLL. No variable tested in the multivariate analysis was found to significantly affect these outcomes, including having failed fludarabine. Within the limitations of this study, we found no difference in HLA-identical sibling transplantation outcomes between myeloablative TBI and chemotherapy pretransplantation conditioning in persons with CLL.

AB - An allogeneic hematopoietic cell transplantation from an HLA-identical donor after high-dose (myeloablative) pretransplantation conditioning is an effective therapy for some people with chronic lymphocytic leukemia (CLL). Because CLL is a highly radiosensitive cancer, we hypothesized that total body irradiation (TBI) conditioning regimens may be associated with better outcomes than those without TBI. To answer this, we analyzed data from 180 subjects with CLL receiving myeloablative doses of TBI (n=126) or not (n=54), who received transplants from an HLA-identical sibling donor between 1995 and 2007 and reported to the Center for International Blood & Marrow Transplant Research. At 5years, treatment-related mortality was 48% (95% confidence interval [CI], 39% to 57%) versus 50% (95% CI, 36% to 64%); P= NS. Relapse rates were 17% (95% CI, 11% to 25%) versus 22% (95% CI, 11% to 35%); P= NS. Five-year progression-free survival and overall survival were 34% (95% CI, 26% to 43%) versus 28% (95% CI, 15% to 42%); P= NS and 42% (95% CI, 33% to 51%) versus 33% (95% CI, 19% to 48%); P= NS, respectively. The single most common cause of death in both cohorts was recurrent/progressive CLL. No variable tested in the multivariate analysis was found to significantly affect these outcomes, including having failed fludarabine. Within the limitations of this study, we found no difference in HLA-identical sibling transplantation outcomes between myeloablative TBI and chemotherapy pretransplantation conditioning in persons with CLL.

KW - Chronic lymphocytic leukemia

KW - Conditioning

KW - Myeloablative

KW - Total body irradiation

UR - http://www.scopus.com/inward/record.url?scp=84896865427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896865427&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2013.11.032

DO - 10.1016/j.bbmt.2013.11.032

M3 - Article

C2 - 24321745

AN - SCOPUS:84896865427

VL - 20

SP - 421

EP - 424

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 3

ER -